Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC
Clinical trial NCT06519721 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06519721
- Sponsor
- RenJi Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-06
- Primary completion
- 2025-12-24
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.